Evidence map›Paper›PMID 30344923›Full record

ArticleOncotarget2018

Genetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of

Sara Ciceri, Beatrice Gamba, Paola Corbetta, Patrizia Mondini, Monica Terenziani, Serena Catania, Marilina Nantron, Maurizio Bianchi, Paolo D'Angelo, Federica Torri and 9 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 18 citations in OpenAlex.

  1. Wilms tumor characteristics in children with heterozygous germline DIS3L2 variants.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Cancers · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Cells · 2020
    Review
  11. [MicroRNA-200c-3p inhibits proliferation of nephroblastoma cells by targeting CCNE2].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
  12. Article
  13. Review
  14. The association ofJournal of Cancer · 2020
    Article
  15. Article
  16. Article
  17. Annals of translational medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Sara CiceriMolecular Bases of Genetic Risk and Genetic Testing Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Beatrice GambaMolecular Bases of Genetic Risk and Genetic Testing Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Paola CorbettaMolecular Bases of Genetic Risk and Genetic Testing Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Patrizia MondiniMolecular Bases of Genetic Risk and Genetic Testing Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Monica TerenzianiPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Serena CataniaPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Marilina NantronDepartment of Hematology and Oncology, Istituto G. Gaslini, Genova, Italy.
Maurizio BianchiPediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Torino, Italy.
Paolo D'AngeloPediatric Oncology Unit, A.R.N.A.S. Ospedali Civico, Di Cristina e Benfratelli, Palermo, Italy.
Federica TorriDepartment of Psychiatry and Human Behavior, School of Medicine, University of California, Irvine, CA, USA.
Fabio MacciardiDepartment of Psychiatry and Human Behavior, School of Medicine, University of California, Irvine, CA, USA.
Paola ColliniSoft Tissue and Bone Pathology, Histopathology, and Pediatric Pathology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Martina Di MartinoPediatric Oncology Unit, Pediatric Department, II University, Naples, Italy.
Fraia MelchiondaPediatric Hematology and Oncology Unit, Bologna University, Bologna, Italy.
Andrea Di CataldoPediatric Hematology and Oncology Unit, Catania University, Catania, Italy.
Filippo SpreaficoPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Paolo RadiceMolecular Bases of Genetic Risk and Genetic Testing Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Daniela PerottiMolecular Bases of Genetic Risk and Genetic Testing Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
AIEOP study group
Fondazione IRCCS Istituto Nazionale dei Tumori · ITUniversity of California, Irvine · USFederico II University Hospital · ITIstituto Giannina Gaslini · ITUniversity of Catania · ITOspedale Regina Margherita · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wilms tumour (WT), the most frequent malignant childhood renal tumour, shows a high degree of genetic and epigenetic heterogeneity. Loss of imprinting on chromosome 11p15 is found in a large fraction of cases and mutations in a few genes, including

Indexed as

CHEK2SNP arrayWilms tumor

Identifiers

PMID30344923
PMCPMC6183341
OpenAlexW2894513918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.